நிறுவனம் சர்வபுலம் ஊக்கத்தொகை திட்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் சர்வபுலம் ஊக்கத்தொகை திட்டம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் சர்வபுலம் ஊக்கத்தொகை திட்டம் Today - Breaking & Trending Today

On the Move – Greenlane Renewables, Circa Group, USGC's Global Ethanol Market Development, Eco Wave Power, BASF and more : Biofuels Digest


In a rare occurrence in the biobased economy, we saw more women on the move than men so far this summer. From Greenlane Renewables new Lead Director, Circa Group’s new CFO, U.S. Grains Council’s new Manager of Global Ethanol Market Development, and others, women took the lead over the past month or so with movements, promotions, appointments in the biobased sector. Check out all the latest moves from your friends and colleagues in the bio sectors.
If you have an “On the Move” for us to cover, please contact Helena Kennedy at [email protected].
Greenlane Renewables Appoints Lead Director and Amends Omnibus Incentive Plan ....

North Carolina , United States , Nicola Noponen , Francois Scheffler , Helena Kennedy , Amandal Hays , Elaine Wong , Stella Qian , Thilo Bischoff , Asia Pacific , Amanda Keogh , Reinhardt Peper , Company Omnibus Incentive Plan , Greenlane Renewables Inc , Us Grains Council , Phd To Team As Scientific , Standard Development , Greenlane Renewables , Greenlane Renewables Appoints , Nutrition Health , Circa Group , Company Founder Pascal Boulanger , Global Ethanol Market Development , Corporate Development Committee , Lead Director , Renewables Appoints Lead Director ,

Greenlane Renewables Announces Appointment of Lead Director and Amendment to Omnibus Incentive Plan

LexaGene Takes Steps to List on the Nasdaq


Message :
Required fields
Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it is taking steps to list its common shares on the Nasdaq Capital Market with the goal of submitting its application prior to the end of 2021. A successful listing on the Nasdaq will make the Company’s shares more accessible to retail and institutional investors in the United States and internationally as well as increase share liquidity. The Nasdaq is the Company’s preferred Exchange as it hosts the best biotech and life science companies in the world.
LexaGene has taken several steps to prepare for a Nasdaq listing application. ....

New York , United States , Peter Handrinos , Jack Regan , Company Share , Company Omnibus Incentive Plan , Latham Watkins , Pads Inc , Compensia Inc , Lexagene Holdings Inc , Exchange Commission , Nasdaq Exchange , Gene Holdings , Nasdaq Capital Market , Annual Report , Canadian Securities Form , Native Ads , Omnibus Incentive Plan , Performance Conditions , Company Shares , Performance Options , Lexagene Holdings Inc Stock Exchange , Press Release , T Lxg Ca52886l1031 , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் ,

LexaGene Expands its Sales Team


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
LexaGene Expands its Sales Team
LexaGene Holdings IncMay 11, 2021 GMT
BEVERLY, Mass., May 11, 2021 (GLOBE NEWSWIRE) LexaGene Holdings, Inc., ( TSX-V: LXG; OTCQB: LXXGF ) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the hiring of four additional sales representatives, including three for the veterinary market and one for the contract drug manufacturing market.
ADVERTISEMENT
Dr. Jack Regan, LexaGene’s CEO and Founder states, “We are excited to have recruited very talented and experienced sales representatives from some of the biggest names in veterinary healthcare. Our new sales representatives have universally expressed optimism about selling LexaGene’s technology into veterinary hospitals, and the same is true for our sales representative targeting contract drug ma ....

United States , Jeff Mitchell , Sarah Mumbower , Jack Regan , Company Share , College Of Charleston , Census Bureau , Bayer Animal Health Elanco , Company Omnibus Incentive Plan , Lexagene Holdings Inc , Us Department Of Labor , University Of Massachusetts , Venture Exchange On , Venture Exchange Inc , American Regent Animal Health , Carolina State University , Venture Exchange , Regulation Services Provider , Gene Holdings , West Regional Sales , Village Animal Clinic , Sunburst Animal , Certified Veterinary , Southeast Regional Sales , Bayer Animal Health , Northeast Regional Sales ,

Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program


Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program
December 23, 2020 16:15 ET
| Source:
Amedisys, Inc.
Amedisys, Inc.
Baton Rouge, Louisiana, UNITED STATES
BATON ROUGE, La., Dec. 23, 2020 (GLOBE NEWSWIRE) Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to $100 million of its outstanding common stock through December 31, 2021.
Scott Ginn, Chief Financial Officer, stated, “Given our strong cashflow and low leverage, we feel it is prudent to have authorization to buy-back shares throughout the course of the year, including shares granted under the Company’s Omnibus Incentive Plan as they vest in 2021. This will become a recurring part of our capital deployment strategy; however, our firs ....

United States , District Of Columbia , Scott Ginn , Amedisys Inc , Company Omnibus Incentive Plan , Home Health , Chief Financial Officer , Omnibus Incentive Plan , Baton Rouge , ஒன்றுபட்டது மாநிலங்களில் , மாவட்டம் ஆஃப் கொலம்பியா , ஸ்காட் ஜின் , அமெடிஸிஸ் இன்க் , நிறுவனம் சர்வபுலம் ஊக்கத்தொகை திட்டம் , வீடு ஆரோக்கியம் , தலைமை நிதி அதிகாரி , சர்வபுலம் ஊக்கத்தொகை திட்டம் , தடியடி ரூஜ் ,